Studies on opioid peptides as endogenous anticonvulsants

Area of Science:

• Neuroscience
• Pharmacology
• Endocrinology

Background:

• Electroconvulsive shock (ECS) is a treatment for severe depression.
• The mechanisms underlying ECS's therapeutic effects, particularly its impact on seizure threshold, are not fully understood.
• Opioid peptides are endogenous substances with diverse neuromodulatory functions.

Purpose of the Study:

• To investigate the effect of ECS on seizure threshold in rats.
• To explore the role of opioid systems in ECS-induced changes in seizure threshold.
• To examine the influence of hypophysectomy on ECS-induced anticonvulsant effects.

Main Methods:

• Rats (normal and hypophysectomized) were subjected to electroconvulsive shock (ECS).
• Seizure threshold was measured using flurothyl, a volatile convulsant.
• Naloxone, an opioid antagonist, and bicuculline, a convulsant, were administered to assess their effects on seizure threshold and ECS response.

Main Results:

• ECS significantly increased seizure threshold in both normal and hypophysectomized rats.
• Naloxone markedly attenuated the ECS-induced rise in seizure threshold, without affecting basal threshold.
• Hypophysectomy did not influence the ECS-induced increase in seizure threshold or its attenuation by naloxone.

Conclusions:

• The postictal rise in seizure threshold following ECS may involve central mechanisms.
• Brain opioid peptides are suggested to act as endogenous anticonvulsants, potentially preventing sustained seizure activity.
• The pituitary gland does not appear to mediate the anticonvulsant effects of ECS observed in this study.